| HOME >> BIOLOGY >> TECHNOLOGY |
2007 2006
Assets
Current assets:
Cash and cash equivalents:
Cash and commercial paper $ 64,726 $18,697
Reverse repurchase agreements - 54,378
Total cash and cash equivalents 64,726 73,075
Investment securities 6,889 24,668
Accounts receivable 199 516
Unbilled accounts receivable - 7,164
Due from related party - 284
Prepaid expenses and other current assets 1,167 2,544
Total current assets 72,981 108,251
Property and equipment, net 10,806 28,417
Restricted cash 1,556 2,895
Other assets 4,622 2,497
Total assets $89,965 $142,060
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable $2,151 $4,660
Accrued and other current liabilities 2,326 5,553
Derivative liability 3,500 8,220
Due to related party - 57
Total current liabilities 7,977 18,490
Convertible senior subordinated notes 30,679 30,321
Deferred rent and other liabilities 4,270 4,188
Total liabilities 42,926 52,999
Stockholders' equity:
Preferred sto
'/>"/>
| SOURCE VaxGen Inc. Copyright©2008 PR Newswire. All rights reserved |